Leptin showed the capacity to upregulate eNOS phosphorylation and NO production through the adenosine monophosphate (AMP)-activated protein kinase (AMPK). Leptin's vasodilation properties contradict the belief that hyperleptinemia induces hypertension in obese patients [25]. Here, NOS3 is linked to hypertensive disorder.